Japan, May 13 -- CODAGENIX INC,UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES has got intellectual property rights for 'VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES.' Other related details are as follows:
Application Number: JP,2024-178707
Category (FI): C12N15/40,C12N15/34,C12N15/113,100@Z,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,A61K9/08,A61K9/72,A61K39/155,A61P31/14,A61P37/04,A61K39/12
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 11, 2024
Publication Date: Feb. 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....